Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Jansen

Showing results (631-640 of 703) with videos related to

Pageof 71
Sort By:
Annals of the Rheumatic Diseases|July 16, 2008
Evaluating guidelines on continuation of anti-tumour necrosis factor treatment after 3 months: clinical effectiveness and costs of observed care and different alternative strategiesW Kievit, J Fransen, E M Adang, et al.
Antimicrobial Resistance and Infection Control|May 26, 2018
Dynamics of colistin and tobramycin resistance among <i>Enterobacter cloacae</i> during prolonged use of selective decontamination of the digestive tractM J D Dautzenberg, J R Bayjanov, M A Leverstein-van Hall, et al.
Contemporary Clinical Trials|July 30, 2020
The home air in agriculture pediatric intervention (HAPI) trial: Rationale and methodsErin E Masterson, Lisa B Younglove, Adriana Perez, et al.
The Journal of Rheumatology|September 3, 2011
Effectiveness of a third tumor necrosis factor-α-blocking agent compared with rituximab after failure of 2 TNF-blocking agents in rheumatoid arthritisMarlies Blom, Wietske Kievit, A Rogier T Donders, et al.
Environmental Health : a Global Access Science Source|January 4, 2022
Randomized trial of a portable HEPA air cleaner intervention to reduce asthma morbidity among Latino children in an agricultural communityRebecca L Drieling, Paul D Sampson, Jennifer E Krenz, et al.
Hepatology (Baltimore, Md.)|August 1, 1996
Current therapy for Crigler-Najjar syndrome type 1: report of a world registryC N van der Veere, M Sinaasappel, A F McDonagh, et al.
Gastroenterology|November 7, 2016
Distinct Patterns of Somatic Mosaicism in the APC Gene in Neoplasms From Patients With Unexplained Adenomatous PolyposisAnne M L Jansen, Stijn Crobach, Willemina R R Geurts-Giele, et al.
Arthritis Research & Therapy|May 23, 2015
Cost-effectiveness of abatacept, rituximab, and TNFi treatment after previous failure with TNFi treatment in rheumatoid arthritis: a pragmatic multi-centre randomised trialSofie H M Manders, Wietske Kievit, Eddy Adang, et al.
Plos One|April 3, 2020
Preventability of unplanned readmissions within 30 days of discharge. A cross-sectional, single-center studyAlbertine M B van der Does, Eva L Kneepkens, Elien B Uitvlugt, et al.
Annals of the Rheumatic Diseases|January 5, 2008
The effectiveness and medication costs of three anti-tumour necrosis factor alpha agents in the treatment of rheumatoid arthritis from prospective clinical practice dataW Kievit, E M Adang, J Fransen, et al.
Pageof 71

Showing results (631-640 of 703) with videos related to

Sort By:
Pageof 71
Annals of the Rheumatic Diseases|July 16, 2008
Evaluating guidelines on continuation of anti-tumour necrosis factor treatment after 3 months: clinical effectiveness and costs of observed care and different alternative strategiesW Kievit, J Fransen, E M Adang, et al.
Antimicrobial Resistance and Infection Control|May 26, 2018
Dynamics of colistin and tobramycin resistance among <i>Enterobacter cloacae</i> during prolonged use of selective decontamination of the digestive tractM J D Dautzenberg, J R Bayjanov, M A Leverstein-van Hall, et al.
Contemporary Clinical Trials|July 30, 2020
The home air in agriculture pediatric intervention (HAPI) trial: Rationale and methodsErin E Masterson, Lisa B Younglove, Adriana Perez, et al.
The Journal of Rheumatology|September 3, 2011
Effectiveness of a third tumor necrosis factor-α-blocking agent compared with rituximab after failure of 2 TNF-blocking agents in rheumatoid arthritisMarlies Blom, Wietske Kievit, A Rogier T Donders, et al.
Environmental Health : a Global Access Science Source|January 4, 2022
Randomized trial of a portable HEPA air cleaner intervention to reduce asthma morbidity among Latino children in an agricultural communityRebecca L Drieling, Paul D Sampson, Jennifer E Krenz, et al.
Hepatology (Baltimore, Md.)|August 1, 1996
Current therapy for Crigler-Najjar syndrome type 1: report of a world registryC N van der Veere, M Sinaasappel, A F McDonagh, et al.
Gastroenterology|November 7, 2016
Distinct Patterns of Somatic Mosaicism in the APC Gene in Neoplasms From Patients With Unexplained Adenomatous PolyposisAnne M L Jansen, Stijn Crobach, Willemina R R Geurts-Giele, et al.
Arthritis Research & Therapy|May 23, 2015
Cost-effectiveness of abatacept, rituximab, and TNFi treatment after previous failure with TNFi treatment in rheumatoid arthritis: a pragmatic multi-centre randomised trialSofie H M Manders, Wietske Kievit, Eddy Adang, et al.
Plos One|April 3, 2020
Preventability of unplanned readmissions within 30 days of discharge. A cross-sectional, single-center studyAlbertine M B van der Does, Eva L Kneepkens, Elien B Uitvlugt, et al.
Annals of the Rheumatic Diseases|January 5, 2008
The effectiveness and medication costs of three anti-tumour necrosis factor alpha agents in the treatment of rheumatoid arthritis from prospective clinical practice dataW Kievit, E M Adang, J Fransen, et al.
Pageof 71